Relative Risk Perceptions of Switching to JUUL vs. Continued Smoking and Subsequent Switching away from Cigarettes: A Longitudinal Observational Study
preprint
OA: closed
CC-BY-4.0
Abstract
Background: Evidence indicates that electronic nicotine delivery systems (ENDS) pose lower risk than cigarettes; however, many smokers misperceive ENDS to be equally or more harmful, possibly deterring them from switching. This study examines whether relative risk perceptions of JUUL vs. smoking are associated with subsequent switching, among smokers who recently initiated JUUL use. Methods: : N=16,996 current established smokers who recently purchased a JUUL Starter Kit were followed 6 times over 12 months. Relative risk perceptions were assessed using both direct and indirect measures (i.e., contrasting JUUL and smoking directly in questions, and deriving from separate absolute scales). Repeated-measures logistic regression examined switching across follow-up (no smoking in past 30 days) as a function of baseline risk perceptions, adjusting for demographics and baseline smoking behavior. Results: : Perceiving JUUL as less harmful than smoking was associated with higher switching rates, using both direct (e.g., odds ratio [OR]=1.48 for “JUUL much less” vs. “more/much more harmful”) and indirect (OR=1.07, for each 10-unit increase in ratio; OR=1.51 for highest (6-100) vs. lowest (0 to <1) ratio categories) relative risk measures (all p <.0001). Among the subset smoking 10+ cigarettes per day, associations between risk perceptions and switching were more pronounced (OR=2.51 for “JUUL much less” vs. “more/much more harmful”; OR=1.81 for 6-100 vs. 0 to <1 ratio, both p <.0001). Conclusions: : Smokers who perceive JUUL as less harmful than cigarettes have higher odds of switching. Future research should examine whether messaging which aligns relative risk perceptions with current evidence can facilitate switching, especially among heavier smokers.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (32)
- doi:10.2105/ajph.2021.306416 via crossref
- doi:10.1007/s11166-020-09329-2 via crossref
- doi:10.1093/ntr/ntac088 via crossref
- doi:10.1111/dar.13024 via crossref
- doi:10.1111/j.1360-0443.1987.tb01492.x via crossref
- doi:10.1037/h0053870 via crossref
- doi:10.1016/0749-5978(91)90020-t via crossref
- doi:10.1177/109019818401100101 via crossref
- doi:10.1177/109019817400200405 via crossref
- doi:10.1037/0278-6133.26.2.136 via crossref
- doi:10.1007/s10865-021-00202-4 via crossref
- doi:10.1080/15389588.2019.1673893 via crossref
- doi:10.1136/tobaccocontrol-2018-054315 via crossref
- doi:10.3390/ijerph18020576 via crossref
- doi:10.1080/10410236.2017.1407226 via crossref
- doi:10.1136/tobaccocontrol-2021-057190 via crossref
- doi:10.1016/j.ypmed.2016.09.011 via crossref
- doi:10.3390/ijerph17238865 via crossref
- doi:10.1111/add.14730 via crossref
- doi:10.5993/ajhb.45.3.3 via crossref
- doi:10.1016/j.drugalcdep.2021.109238 via crossref
- doi:10.1093/ntr/ntz213 via crossref
- doi:10.1016/j.abrep.2020.100254 via crossref
- doi:10.1016/j.jadohealth.2018.04.010 via crossref
- doi:10.3390/ijerph16020184 via crossref
- doi:10.1016/j.drugalcdep.2015.01.001 via crossref
- doi:10.1136/tobaccocontrol-2017-053808 via crossref
- doi:10.1093/ntr/ntz114 via crossref
- doi:10.1186/s12889-021-12103-x via crossref
- doi:10.1186/s12889-022-13983-3 via crossref
- doi:10.1016/j.addbeh.2011.02.002 via crossref
- doi:10.1093/ntr/ntab005 via crossref
Source provenance
- crossref
- last seen: 2026-05-29T01:00:29.746990+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0